Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 39, 2010 - Issue 6
Submit an article Journal homepage
230
Views
45
CrossRef citations to date
0
Altmetric
Articles

Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity

N Vuilleumier Department of Rheumatology, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden; Clinical Chemistry, Department of Genetics and Laboratory Medicine, Geneva University Hospitals and University of Geneva, Switzerland
,
J Bratt Department of Rheumatology, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden
,
R Alizadeh Department of Clinical Physiology, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden
,
T Jogestrand Department of Clinical Physiology, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden
,
I Hafström Department of Rheumatology, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, SwedenCorrespondence[email protected]
&
J Frostegård Department of Rheumatology, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden
Pages 447-453 | Accepted 02 Mar 2010, Published online: 06 Jul 2010

Citations (45)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

TD Filippatos, CS Derdemezis, PV Voulgari, V Tsimihodimos, MS Elisaf, AD Tselepis & AA Drosos. (2013) Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study. Scandinavian Journal of Rheumatology 42:3, pages 169-175.
Read now
N Knowlton, JA Wages, MB Centola & P Alaupovic. (2012) Apolipoprotein-defined lipoprotein abnormalities in rheumatoid arthritis patients and their potential impact on cardiovascular disease. Scandinavian Journal of Rheumatology 41:3, pages 165-169.
Read now
L-S Tam, EK Li, Q Shang, B Tomlinson, VW Lee, KK Lee, M Li, W Pang Kuan, TK Li, L Tseung, GWK Yip, B Freedman & C-M Yu. (2011) Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial. Scandinavian Journal of Rheumatology 40:6, pages 411-421.
Read now

Articles from other publishers (42)

Mustafa Al-Maini, Mahesh Maindarkar, George D. Kitas, Narendra N. Khanna, Durga Prasanna Misra, Amer M. Johri, Laura Mantella, Vikas Agarwal, Aman Sharma, Inder M. Singh, George Tsoulfas, John R. Laird, Gavino Faa, Jagjit Teji, Monika Turk, Klaudija Viskovic, Zoltan Ruzsa, Sophie Mavrogeni, Vijay Rathore, Martin Miner, Manudeep K. Kalra, Esma R. Isenovic, Luca Saba, Mostafa M. Fouda & Jasjit S. Suri. (2023) Artificial intelligence-based preventive, personalized and precision medicine for cardiovascular disease/stroke risk assessment in rheumatoid arthritis patients: a narrative review. Rheumatology International.
Crossref
G. V. Papamichail, A. N. Georgiadis, C. C. Tellis, I. Rapti, T. E. Markatseli, V. G. Xydis, A. D. Tselepis, A. A. Drosos & P. V. Voulgari. (2023) Antibodies against oxidized LDL and atherosclerosis in rheumatoid arthritis patients treated with biological agents: a prospective controlled study. Clinical Rheumatology.
Crossref
Saseong Lee, Eunbyeol Choi, Sehyun Chae, Jung Hee Koh, Yoolim Choi, Jung Gon Kim, Seung-Ah Yoo, Daehee Hwang & Wan-Uk Kim. (2023) Identification of MYH9 as a key regulator for synoviocyte migration and invasion through secretome profiling. Annals of the Rheumatic Diseases 82:8, pages 1035-1048.
Crossref
Javier Rodríguez-Carrio, Mercedes Alperi-López, Patricia López, Ángel I Pérez-Álvarez, George A Robinson, Sara Alonso-Castro, Núria Amigo-Grau, Fabiola Atzeni & Ana Suárez. (2023) Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages. Rheumatology 62:8, pages 2898-2907.
Crossref
Nur ALIM. (2023) The Potency of Beligo Seeds (Benincasa hispida (Thunb.) Cogn.) as Antihyperlipidemic in L-NAME-induced Hyperlipidemic Rats. Fabad Journal of Pharmaceutical Sciences.
Crossref
Roman Máčalík, Marek Petráš, Alexander M. Čelko, Petr Chmátal, Jakub Tlapák, Pavel Dlouhý, Jana Malinová & Ivana Králová Lesná. (2023) BMI-Associated Anti-Apolipoprotein A-1 Positivity in Healthy Adults after mRNA-Vaccination against COVID-19. Vaccines 11:3, pages 670.
Crossref
Gerwyn Morris, Michael Berk, Ken Walder, Adrienne O’Neil, Michael Maes & Basant K. Puri. (2021) The lipid paradox in neuroprogressive disorders: Causes and consequences. Neuroscience & Biobehavioral Reviews 128, pages 35-57.
Crossref
Weilin Chen, Qi Wang, Bin Zhou, Lihua Zhang & Honglin Zhu. (2021) Lipid Metabolism Profiles in Rheumatic Diseases. Frontiers in Pharmacology 12.
Crossref
Rashita Makkar, Tapan Behl, Arun Kumar, Md. Sahab Uddin & Simona Bungau. (2020) Untying the correlation between apolipoproteins and rheumatoid arthritis. Inflammation Research 70:1, pages 19-28.
Crossref
Minzhi Yu, Sang Y. Kim, Emily E. Morin & Anna Schwendeman. (2020) Reply. Arthritis & Rheumatology 72:7, pages 1234-1236.
Crossref
Anouar Hafiane, Elda Favari, Stella S. Daskalopoulou, Nicolas Vuilleumier & Miguel A. Frias. (2020) High-density lipoprotein cholesterol efflux capacity and cardiovascular risk in autoimmune and non-autoimmune diseases. Metabolism 104, pages 154141.
Crossref
Charlotte Mungho Tata, Constance Rufaro Sewani-Rusike, Opeoluwa Oyehan Oyedeji, Ephraim Tobela Gwebu, Fikile Mahlakata & Benedicta Ngwenchi Nkeh-Chungag. (2019) Antihypertensive effects of the hydro-ethanol extract of Senecio serratuloides DC in rats. BMC Complementary and Alternative Medicine 19:1.
Crossref
Nathalie Satta, Miguel A. Frias, Nicolas Vuilleumier & Sabrina Pagano. (2019) Humoral Immunity Against HDL Particle: A New Perspective in Cardiovascular Diseases?. Current Pharmaceutical Design 25:29, pages 3128-3146.
Crossref
Narendra N. Khanna, Ankush D. Jamthikar, Deep Gupta, Matteo Piga, Luca Saba, Carlo Carcassi, Argiris A. Giannopoulos, Andrew Nicolaides, John R. Laird, Harman S. Suri, Sophie Mavrogeni, A.D. Protogerou, Petros Sfikakis, George D. Kitas & Jasjit S. Suri. (2019) Rheumatoid Arthritis: Atherosclerosis Imaging and Cardiovascular Risk Assessment Using Machine and Deep Learning–Based Tissue Characterization. Current Atherosclerosis Reports 21:2.
Crossref
J. O. Lagerstedt, J. Dalla‐Riva, G. Marinkovic, R. Del Giudice, D. Engelbertsen, J. Burlin, J. Petrlova, M. Lindahl, K. Bernfur, O. Melander, J. Nilsson & A. Schiopu. (2018) Anti‐ApoA‐I IgG antibodies are not associated with carotid artery disease progression and first‐time cardiovascular events in middle‐aged individuals. Journal of Internal Medicine 285:1, pages 49-58.
Crossref
Joo Youn Lee, Min Jueng Kang, Ji Yong Choi, Ji Soo Park, Jin Kyun Park, Eun Young Lee, Eun Bong Lee, Thomas Pap, Eugene C Yi & Yeong Wook Song. (2018) Apolipoprotein B binds to enolase-1 and aggravates inflammation in rheumatoid arthritis. Annals of the Rheumatic Diseases 77:10, pages 1480-1489.
Crossref
Panagiotis Antiochos, Pedro Marques-Vidal, Julien Virzi, Sabrina Pagano, Nathalie Satta, Oliver Hartley, Fabrizio Montecucco, François Mach, Zoltán Kutalik, Gerard Waeber, Peter Vollenweider & Nicolas Vuilleumier. (2017) Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 Polymorphisms. Frontiers in Immunology 8.
Crossref
Moisés Evandro Bauer & Mónica De la Fuente. (2016) The role of oxidative and inflammatory stress and persistent viral infections in immunosenescence. Mechanisms of Ageing and Development 158, pages 27-37.
Crossref
Dimitry A Chistiakov, Alexander N Orekhov & Yuri V Bobryshev. (2016) ApoA1 and ApoA1-specific self-antibodies in cardiovascular disease. Laboratory Investigation 96:7, pages 708-718.
Crossref
Dalia El-Lebedy, Enas Rasheed, Mona Kafoury, Dalia Abd-El Haleem, Eman Awadallah & Ingy Ashmawy. (2016) Anti-apolipoprotein A-1 autoantibodies as risk biomarker for cardiovascular diseases in type 2 diabetes mellitus. Journal of Diabetes and its Complications 30:4, pages 580-585.
Crossref
Panagiotis Antiochos, Pedro Marques-Vidal, Julien Virzi, Sabrina Pagano, Nathalie Satta, François Bastardot, Oliver Hartley, Fabrizio Montecucco, François Mach, Gerard Waeber, Peter Vollenweider & Nicolas Vuilleumier. (2017) Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Thrombosis and Haemostasis 116:10, pages 764-771.
Crossref
Sabrina Pagano, Federico Carbone, Fabienne Burger, Aline Roth, Maria Bertolotto, Bianca Pane, Giovanni Spinella, Domenico Palombo, Aldo Pende, Franco Dallegri, Nathalie Satta, Julien Virzi, Pierre Fontana, François Mach, Fabrizio Montecucco & Nicolas Vuilleumier. (2017) Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis. Thrombosis and Haemostasis 116:09, pages 554-564.
Crossref
Sabrina Pagano, Hubert Gaertner, Fabrice Cerini, Tiphaine Mannic, Nathalie Satta, Priscila Camillo Teixeira, Paul Cutler, François Mach, Nicolas Vuilleumier & Oliver Hartley. (2015) The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?. PLOS ONE 10:7, pages e0132780.
Crossref
Priscila Camillo Teixeira, Philippe Ferber, Nicolas Vuilleumier & Paul Cutler. (2015) Biomarkers for cardiovascular risk assessment in autoimmune diseases. PROTEOMICS – Clinical Applications 9:1-2, pages 48-57.
Crossref
Priscila Camillo Teixeira, Axel Ducret, Philippe Ferber, Hubert Gaertner, Oliver Hartley, Sabrina Pagano, Michelle Butterfield, Hanno Langen, Nicolas Vuilleumier & Paul Cutler. (2014) Definition of Human Apolipoprotein A-I Epitopes Recognized by Autoantibodies Present in Patients with Cardiovascular Diseases. Journal of Biological Chemistry 289:41, pages 28249-28259.
Crossref
Carmen García-Gómez. (2014) Inflammation, lipid metabolism and cardiovascular risk in rheumatoid arthritis: A qualitative relationship?. World Journal of Orthopedics 5:3, pages 304.
Crossref
Jenny Amaya-Amaya, Laura Montoya-Sánchez & Adriana Rojas-Villarraga. (2014) Cardiovascular Involvement in Autoimmune Diseases. BioMed Research International 2014, pages 1-31.
Crossref
D.F. van Breukelen-van der Stoep, B. Klop, D. van Zeben, J.M.W. Hazes & M. Castro Cabezas. (2013) Cardiovascular risk in rheumatoid arthritis: How to lower the risk?. Atherosclerosis 231:1, pages 163-172.
Crossref
Jenny Amaya-Amaya, Juan Camilo Sarmiento-Monroy, Ruben-Dario Mantilla, Ricardo Pineda-Tamayo, Adriana Rojas-Villarraga & Juan-Manuel Anaya. (2013) Novel risk factors for cardiovascular disease in rheumatoid arthritis. Immunologic Research 56:2-3, pages 267-286.
Crossref
P. Roux-Lombard, S. Pagano, F. Montecucco, N. Satta & N. Vuilleumier. (2010) Auto-antibodies as Emergent Prognostic Markers and Possible Mediators of Ischemic Cardiovascular Diseases. Clinical Reviews in Allergy & Immunology 44:1, pages 84-97.
Crossref
Nicolas Vuilleumier, Fabrizio Montecucco, Giovanni Spinella, Sabrina Pagano, Maria Bertolotto, Bianca Pane, Aldo Pende, Katia Galan, Pascale Roux-Lombard, Christophe Combescure, Franco Dallegri, François Mach & Domenico Palombo. (2017) Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy. Thrombosis and Haemostasis 109:04, pages 706-715.
Crossref
Menno Pruijm, Jan Schmidtko, Anthony Aho, Sabrina Pagano, Pascale Roux-Lombard, Daniel Teta, Michel Burnier & Nicolas Vuilleumier. (2012) High Prevalence of Anti-Apolipoprotein/A-1 Autoantibodies in Maintenance Hemodialysis and Association With Dialysis Vintage. Therapeutic Apheresis and Dialysis 16:6, pages 588-594.
Crossref
S. Pagano, N. Satta, D. Werling, V. Offord, P. de Moerloose, E. Charbonney, D. Hochstrasser, P. Roux-Lombard & N. Vuilleumier. (2012) Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex. Journal of Internal Medicine 272:4, pages 344-357.
Crossref
SOFIA AJEGANOVA, ULF de FAIRE, TOMAS JOGESTRAND, JOHAN FROSTEGÅRD & INGIÄLD HAFSTRÖM. (2012) Carotid Atherosclerosis, Disease Measures, Oxidized Low-density Lipoproteins, and Atheroprotective Natural Antibodies for Cardiovascular Disease in Early Rheumatoid Arthritis — An Inception Cohort Study. The Journal of Rheumatology 39:6, pages 1146-1154.
Crossref
Axel Finckh, Delphine S. Courvoisier, Sabrina Pagano, Sylvette Bas, Paola Chevallier‐Ruggeri, Denis Hochstrasser, Pascale Roux‐Lombard, Cem Gabay & Nicolas Vuilleumier. (2012) Evaluation of cardiovascular risk in patients with rheumatoid arthritis: Do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?. Arthritis Care & Research 64:6, pages 817-825.
Crossref
P.‐F. Keller, S. Pagano, P. Roux‐Lombard, P. Sigaud, O. T. Rutschmann, F. Mach, D. Hochstrasser & N. Vuilleumier. (2011) Autoantibodies against apolipoprotein A‐1 and phosphorylcholine for diagnosis of non‐ST‐segment elevation myocardial infarction. Journal of Internal Medicine 271:5, pages 451-462.
Crossref
Michel F. Rossier, Sabrina Pagano, Magaly Python, Andres D. Maturana, Richard W. James, François Mach, Pascale Roux-Lombard & Nicolas Vuilleumier. (2012) Antiapolipoprotein A-1 IgG Chronotropic Effects Require Nongenomic Action of Aldosterone on L-Type Calcium Channels. Endocrinology 153:3, pages 1269-1278.
Crossref
P. C. Teixeira, P. Cutler & N. Vuilleumier. (2012) Autoantibodies to Apolipoprotein A-1 in Cardiovascular Diseases: Current Perspectives. Clinical and Developmental Immunology 2012, pages 1-7.
Crossref
Elisabetta Profumo, Manuela Di Franco, Brigitta Buttari, Roberta Masella, Carmelina Filesi, Maria Elena Tosti, Rossana Scrivo, Antongiulio Scarno, Antonio Spadaro, Luciano Saso & Rachele Riganò. (2012) Biomarkers of Subclinical Atherosclerosis in Patients with Autoimmune Disorders. Mediators of Inflammation 2012, pages 1-8.
Crossref
Lorenzo Cavagna, Nicola Boffini, Giovanni Cagnotto, Flora Inverardi, Vittorio Grosso & Roberto Caporali. (2012) Atherosclerosis and Rheumatoid Arthritis: More Than a Simple Association. Mediators of Inflammation 2012, pages 1-8.
Crossref
S. Ajeganova, C. Ehrnfelt, R. Alizadeh, M. Rohani, T. Jogestrand, I. Hafstrom & J. Frostegard. (2011) Longitudinal levels of apolipoproteins and antibodies against phosphorylcholine are independently associated with carotid artery atherosclerosis 5 years after rheumatoid arthritis onset--a prospective cohort study. Rheumatology 50:10, pages 1785-1793.
Crossref
Ivan V. Shirinsky & Valery S. Shirinsky. (2011) Targeting Nuclear Hormone Receptors: PPAR α Agonists as Potential Disease-Modifying Drugs for Rheumatoid Arthritis . International Journal of Rheumatology 2011, pages 1-8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.